Acadia Pharmaceuticals Inc. · NASDAQ:ACAD

Kihara James sold 1,332 Acadia Pharmaceuticals Inc. shares (Form 4)

Traded May 1 to May 4, 2026 · Filed May 5, 2026

From May 1 to May 4, 2026, Kihara James (PRINCIPAL ACCOUNTING OFFICER) sold 1,332 Acadia Pharmaceuticals Inc. shares at US$21.79 for US$29,024, leaving 29,129 shares. Filed May 5, 2026 (Form 4).

Sold
1,332 shares
Price
US$21.79
Value
US$29,024
Holding after
29,129 shares
Trading plan
No
Role
PRINCIPAL ACCOUNTING OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 1, 2026Common StockOption exercise2,59630,461Direct
May 4, 2026Common StockSale1,332US$21.7929,129Direct

Source

View original at SEC

Related